Progress of the treatment of diabetic nephropathy
10.3760/cma.j.issn.1008-6315.2017.06.018
- VernacularTitle:糖尿病肾病的治疗进展
- Author:
Wenrui LIU
;
Lin LIAO
;
Jianrao LU
- Keywords:
Diabetes;
Diabetic nephropathy;
Drug treatment
- From:
Clinical Medicine of China
2017;33(6):547-551
- CountryChina
- Language:Chinese
-
Abstract:
The treatment of diabetic nephropathy (DN) currently extent to control the occurrence and development of it and delay renal failure on a certain stage.However,the effect is not satisfactory.Some traditional hypoglycemic,antihypertensive,lipid and anticoagulant drugs in DN patients with renal protective effect.And some have been in clinical use of drugs such as vitamin D,aldose reductase inhibitors,tripterygium wilfordii glycoside has proved to have the effect of the slow progress in DN,could be used more widely.For new drugs,such as renin inhibitors,phosphodiesterase inhibitors and methyl bartholomew sauron,while partialy was confirmed in a role in the treatment of DN,but before the clinical promotion,its effectiveness and safety still need further study to verify.
